Lugano, 4 October 2018: Reporters are invited to follow the ESMO 2018 Congress, (1) the leading international oncology event in Europe, 19-23 October at the Messe München (2) in Munich, Germany. Journalists will have access to the latest research in oncology and to leading cancer experts from around the world.
The Opening Press Conference (3) will take place on Friday 19 October, 10:45-11:30, and will set the scene of the Congress tagline “Securing access to optimal cancer care”.
There will be four other press briefings (4) presenting clinical trials in:
Breast cancer – Saturday 20 October, 08:15-09:00 Ovarian cancer – Saturday 20 October, 11:15-12:00 Prostate and kidney cancers – Sunday 21 October, 08:15-09:00 Head and neck cancers – Monday 22 October, 08:15-09:00
A wrap up Q&A session for reporters, (3) with ESMO experts from different specialties, is scheduled for Tuesday 23 October at 08:15 and will be the opportunity to ask any unanswered questions.
Other studies to look out for, not included in press briefings, will address, among others:
Is immunotherapy safe for HIV patients with cancer? Do women and men experience the same side effects from chemotherapy? Is Twitter a reliable source for cancer patients? What are the
Article originally posted at